Bank of New York Mellon’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.72M | Buy |
485,672
+12,117
| +3% | +$169K | ﹤0.01% | 2101 |
|
|
2026
Q1 | $4.46M | Sell |
473,555
-10,867
| -2% | -$119K | ﹤0.01% | 2377 |
|
|
2025
Q4 | $6.02M | Buy |
484,422
+90,465
| +23% | +$1.2M | ﹤0.01% | 2218 |
|
|
2025
Q3 | $5.65M | Sell |
393,957
-3,432
| -0.9% | -$47K | ﹤0.01% | 2244 |
|
|
2025
Q2 | $4.88M | Sell |
397,389
-40,126
| -9% | -$583K | ﹤0.01% | 2274 |
|
|
2025
Q1 | $9.62M | Sell |
437,515
-30,447
| -7% | -$716K | ﹤0.01% | 1870 |
|
|
2024
Q4 | $10.6M | Sell |
467,962
-15,830
| -3% | -$346K | ﹤0.01% | 1897 |
|
|
2024
Q3 | $8.79M | Sell |
483,792
-61,709
| -11% | -$1.43M | ﹤0.01% | 1996 |
|
|
2024
Q2 | $15.9M | Sell |
545,501
-45,031
| -8% | -$1.34M | ﹤0.01% | 1716 |
|
|
2024
Q1 | $20.9M | Sell |
590,532
-77,451
| -12% | -$3.1M | ﹤0.01% | 1552 |
|
|
2023
Q4 | $29.1M | Buy |
667,983
+7,284
| +1% | +$287K | 0.01% | 1398 |
|
|
2023
Q3 | $25.2M | Sell |
660,699
-18,283
| -3% | -$769K | 0.01% | 1423 |
|
|
2023
Q2 | $27.9M | Sell |
678,982
-40,955
| -6% | -$1.97M | 0.01% | 1367 |
|
|
2023
Q1 | $41.3M | Sell |
719,937
-4,919
| -0.7% | -$277K | 0.01% | 1128 |
|
|
2022
Q4 | $40.6M | Sell |
724,856
-53,378
| -7% | -$2.72M | 0.01% | 1130 |
|
|
2022
Q3 | $33M | Buy |
778,234
+14,395
| +2% | +$738K | 0.01% | 1198 |
|
|
2022
Q2 | $41.3M | Buy |
763,839
+12,707
| +2% | +$763K | 0.01% | 1107 |
|
|
2022
Q1 | $48.3M | Sell |
751,132
-74,059
| -9% | -$4.88M | 0.01% | 1122 |
|
|
2021
Q4 | $55.3M | Buy |
825,191
+74,161
| +10% | +$5.02M | 0.01% | 1082 |
|
|
2021
Q3 | $51.4M | Buy |
751,030
+85,316
| +13% | +$6.03M | 0.01% | 1104 |
|
|
2021
Q2 | $45.4M | Sell |
665,714
-2,907
| -0.4% | -$206K | 0.01% | 1206 |
|
|
2021
Q1 | $46.2M | Sell |
668,621
-6,730
| -1% | -$456K | 0.01% | 1161 |
|
|
2020
Q4 | $43.8M | Sell |
675,351
-61,247
| -8% | -$3.3M | 0.01% | 1118 |
|
|
2020
Q3 | $34.8M | Sell |
736,598
-30,846
| -4% | -$1.47M | 0.01% | 1118 |
|
|
2020
Q2 | $36.1M | Buy |
767,444
+58,596
| +8% | +$2.88M | 0.01% | 1084 |
|
|
2020
Q1 | $31.7M | Sell |
708,848
-17,035
| -2% | -$894K | 0.01% | 1015 |
|
|
2019
Q4 | $42.3M | Buy |
725,883
+6,333
| +0.9% | +$377K | 0.01% | 1080 |
|
|
2019
Q3 | $43.2M | Sell |
719,550
-13,165
| -2% | -$784K | 0.01% | 1034 |
|
|
2019
Q2 | $40.9M | Buy |
732,715
+660
| +0.1% | +$34K | 0.01% | 1093 |
|
|
2019
Q1 | $40.8M | Sell |
732,055
-2,482
| -0.3% | -$126K | 0.01% | 1097 |
|
|
2018
Q4 | $33.1M | Sell |
734,537
-17,163
| -2% | -$942K | 0.01% | 1146 |
|
|
2018
Q3 | $49.5M | Buy |
751,700
+7,547
| +1% | +$469K | 0.01% | 1022 |
|
|
2018
Q2 | $47.9M | Buy |
744,153
+17,431
| +2% | +$1.08M | 0.01% | 1042 |
|
|
2018
Q1 | $40.2M | Sell |
726,722
-11,432
| -2% | -$599K | 0.01% | 1131 |
|
|
2017
Q4 | $35.3M | Sell |
738,154
-1,015
| -0.1% | -$49.7K | 0.01% | 1214 |
|
|
2017
Q3 | $37.3M | Sell |
739,169
-27,920
| -4% | -$1.43M | 0.01% | 1170 |
|
|
2017
Q2 | $41.8M | Sell |
767,089
-5,159
| -0.7% | -$246K | 0.01% | 1085 |
|
|
2017
Q1 | $32.5M | Sell |
772,248
-357,780
| -32% | -$15.3M | 0.01% | 1243 |
|
|
2016
Q4 | $48.5M | Sell |
1,130,028
-39,260
| -3% | -$1.6M | 0.01% | 957 |
|
|
2016
Q3 | $48.3M | Sell |
1,169,288
-22,234
| -2% | -$931K | 0.01% | 906 |
|
|
2016
Q2 | $47.5M | Sell |
1,191,522
-10,434
| -0.9% | -$375K | 0.01% | 895 |
|
|
2016
Q1 | $40.5M | Buy |
1,201,956
+530,426
| +79% | +$16.5M | 0.01% | 985 |
|
|
2015
Q4 | $22.8M | Sell |
671,530
-4,532
| -0.7% | -$142K | 0.01% | 1322 |
|
|
2015
Q3 | $20.1M | Buy |
676,062
+50,516
| +8% | +$1.58M | 0.01% | 1405 |
|
|
2015
Q2 | $17.2M | Buy |
625,546
+33,864
| +6% | +$902K | ﹤0.01% | 1585 |
|
|
2015
Q1 | $14.9M | Buy |
591,682
+9,417
| +2% | +$223K | ﹤0.01% | 1704 |
|
|
2014
Q4 | $12.9M | Buy |
582,265
+14,458
| +3% | +$293K | ﹤0.01% | 1753 |
|
|
2014
Q3 | $11.5M | Buy |
567,807
+40,450
| +8% | +$805K | ﹤0.01% | 1813 |
|
|
2014
Q2 | $10.1M | Sell |
527,357
-20,337
| -4% | -$379K | ﹤0.01% | 1924 |
|
|
2014
Q1 | $10.3M | Buy |
547,694
+44,232
| +9% | +$854K | ﹤0.01% | 1890 |
|
|
2013
Q4 | $9.82M | Buy |
503,462
+61,876
| +14% | +$1.14M | ﹤0.01% | 1894 |
|
|
2013
Q3 | $7.26M | Sell |
441,586
-90,184
| -17% | -$1.45M | ﹤0.01% | 2004 |
|
|
2013
Q2 | $7.96M | Buy |
+531,770
| New | +$7.79M | ﹤0.01% | 1912 |
|
Other funds holding IART
GT
AIM
LI
Bank of New York Mellon's IART Position: Q2 2026 in Review
Bank of New York Mellon increased its Integra LifeSciences (IART) stake by 2.6% in Q2 2026, buying an estimated $169K and bringing the position to 485,672 shares worth $8.72M. The position accounts for ﹤0.01% of the portfolio, ranked #2101.
Bank of New York Mellon first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $55.3M in Q4 2021. 85 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Bank of New York Mellon held 485,672 shares of Integra LifeSciences worth $8.72M as of Q2 2026.
- Bank of New York Mellon bought 12,117 Integra LifeSciences shares in Q2 2026, an estimated $169K.
- Integra LifeSciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2101 holding.
- Bank of New York Mellon first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Integra LifeSciences position peaked at $55.3M in Q4 2021.
- 85 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.